SCHEMBL30980622

SCHEMBL30980622

CC(=O)N[C@@H]1[C@@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@@H](COCc2ccccc2)O[C@@H]1C#CC#CCCO

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.47
▸ MDM2 Q00987 2/20 0.47
▸ MDM4 O15151 1/20 0.45
▸ HSP90AA1 P07900 1/20 0.45
▸ HSP90AB1 P08238 1/20 0.45
▸ NT5E P21589 1/20 0.41
▸ BCHE P06276 1/20 0.40
▸ TACR2 P21452 3/20 0.40
▸ PTPN1 P18031 6/20 0.40
▸ CDC25B P30305 5/20 0.40
▸ POLB P06746 1/20 0.38
▸ SSTR4 P31391 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ PTPN2 P17706 2/20 0.37
▸ PTPN6 P29350 2/20 0.37
▸ PTPN11 Q06124 2/20 0.37
▸ CDC25A P30304 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30980746 0.89 TP53 (0.44) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980634 0.85 TP53 (0.41) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL31734181 0.84 TP53 (0.52) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980533 0.83 TP53 (0.52) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL31078995 0.82 LMNA (0.43) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL13296098 0.81 TP53 (0.55) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980639 0.80 TP53 (0.41) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL30980528 0.80 TP53 (0.41) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL24378386 0.79 TP53 (0.55) TP53MDM2MDM4HSP90AA1HSP90AB1
SCHEMBL15514084 0.79 TP53 (0.55) TP53MDM2MDM4HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651902-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
WO-2025035040-A1 LYSOSOMAL TARGETING BIFUNCTIONAL MOLECULES FOR DEGRADATION OF MUSCLE-SPECIFIC KINASE AUTOANTIBODIES LYCIA THERAPEUTICS, INC. (US) 2025-02-13 — — WO disclosed
WO-2024155747-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2024-07-25 — — WO disclosed
Send feedback